News › Clinical Practice, Industry News, Patient Care

Sculptra and Restylane Deliver 9-Month Skin, Confidence Boost Post-medication Weight Loss

August 1, 2025

Galderma recently announced final nine-month results from its phase 4 clinical trial confirming that the combination of Sculptra and Restylane Lyft or Contour delivers sustained improvement in facial appearance and high patient satisfaction for individuals facing aesthetic changes due to medication-driven weight loss.

The results, said clinical trial investigator Michael Somenek, MD, represent an evolution in how the aesthetics field can holistically support patients through their weight loss journey, both physically and emotionally.

Read more at Dermatology Times >>

 

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • BTL Establishes New Laser Division and Introduces Exolase One
    • ASPS 2025 Statistics Report Highlights Continued Demand for Aesthetic Treatments, Volume Restoration and Healthy Aging
    • SkinMedica Launches Barrier Calming Cream
    • CEDR HR Solutions Supports AmSpa Members as Platinum Vendor Affiliate
    • Galderma Opens New U.S. and Latin America Headquarters in Miami
Advertisement